Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-03-2021 | Lymphoma | Case report

Antineoplastics

Epstein-Barr virus associated non-Hodgkin's lymphoma and Epstein-Barr virus infection: 2 case reports

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Morales S, et al. Epstein-barr virus infections in patients with BRAFV600E+ multisystem risk organ involvementlangerhans cell histiocytosis. Pediatric Blood and Cancer 68 (Suppl. 1): Jan 2021. Available from: URL: https://doi.org/10.1002/pbc.28808 [abstract] Morales S, et al. Epstein-barr virus infections in patients with BRAFV600E+ multisystem risk organ involvementlangerhans cell histiocytosis. Pediatric Blood and Cancer 68 (Suppl. 1): Jan 2021. Available from: URL: https://​doi.​org/​10.​1002/​pbc.​28808 [abstract]
Metadata
Title
Antineoplastics
Epstein-Barr virus associated non-Hodgkin's lymphoma and Epstein-Barr virus infection: 2 case reports
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-92284-7

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Tramadol

Case report

Alemtuzumab

Case report

Infigratinib

Case report

Pembrolizumab

Case report

Cotrimoxazole